Sarah E Thomas

8PUBLICATIONS
21CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthClinical social work practiceGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 31, 2024
Multi-treatment resistance to biological treatment in patients with psoriasis: Definitions and implications.

N F T Henckens, S E Thomas, J M P A van den Reek

|May 27, 2024
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.

Sarah E Thomas, Marieke M B Seyger, Josje E Mangnus

|Apr 17, 2024
Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis.

Sarah E Thomas, Liana Barenbrug, Gerjon Hannink

|Mar 07, 2024
Unveiling the impact of itch, pain, fatigue and disease severity in paediatric patients with psoriasis and the influence of methotrexate and biologics.

S E Thomas, J M P A van Reek, F M Bruins

|Feb 24, 2024
Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands.

Juul M P A van den Reek, Robert J T van der Leest, Sarah E Thomas

|Aug 18, 2023
How to define a 'super-responder' to biologics in psoriasis studies.

Sarah E Thomas, Juul M P A van den Reek, Marieke M B Seyger

Pageof 2